Publisher Correction: The long tail of oncogenic drivers in prostate cancer

Joshua Armenia^{1

2}, Stephanie A M Wankowicz^{3

4}, David Liu^{3

4}, Jianjiong Gao^{1

2}, Ritika Kundra^{1

2}, Ed Reznik^{1

2}, Walid K Chatila^{1

2}, Debyani Chakravarty^{1

2}, G Celine Han^{3

4}, Ilsa Coleman⁵, Bruce Montgomery⁶, Colin Pritchard⁷, Colm Morrissey⁸, Christopher E Barbieri⁹, Himisha Beltran^{10

11

12}, Andrea Sboner⁹, Zafeiris Zafeiriou¹³, Susana Miranda¹³, Craig M Bielski^{1

2}, Alexander V Penson^{1

2}, Charlotte Tolonen⁴, Franklin W Huang^{3

4}, Dan Robinson¹⁴, Yi Mi Wu¹⁴, Robert Lonigro¹⁴, Levi A Garraway^{3

4}, Francesca Demichelis¹⁵, Philip W Kantoff¹⁶, Mary-Ellen Taplin³, Wassim Abida¹⁶, Barry S Taylor^{1

2

17}, Howard I Scher¹⁶, Peter S Nelson^{5

6}, Johann S de Bono¹³, Mark A Rubin^{9

11

12}, Charles L Sawyers¹, Arul M Chinnaiyan¹⁴; PCF/SU2C International Prostate Cancer Dream Team; Nikolaus Schultz^{18

19

20}, Eliezer M Van Allen^{21

22}

Affiliations

¹ Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
² Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
³ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
⁴ Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
⁵ Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
⁶ Department of Medicine, University of Washington, Seattle, WA, USA.
⁷ Department of Laboratory Medicine, University of Washington, Seattle, WA, USA.
⁸ Department of Urology, University of Washington, Seattle, WA, USA.
⁹ Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
¹⁰ Department of Medicine, Division of Medical Oncology, Weill Cornell Medicine, New York, NY, USA.
¹¹ Englander Institute for Precision Medicine, Weill Cornell Medical College-New York Presbyterian Hospital, New York, NY, USA.
¹² Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College, New York, NY, USA.
¹³ Biomarkers Team, Division of Clinical Studies, The Institute of Cancer Research and Royal Marsden Hospital, London, UK.
¹⁴ Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.
¹⁵ Centre for Integrated Biology, University of Trento, Trento, Italy.
¹⁶ Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
¹⁷ Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
¹⁸ Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. schultzn@mskcc.org.
¹⁹ Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. schultzn@mskcc.org.
²⁰ Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. schultzn@mskcc.org.
²¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. eliezerm_vanallen@dfci.harvard.edu.
²² Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA. eliezerm_vanallen@dfci.harvard.edu.

PMID: 31152158
DOI: 10.1038/s41588-019-0451-6

Published Erratum

Publisher Correction: The long tail of oncogenic drivers in prostate cancer

Joshua Armenia et al. Nat Genet. 2019 Jul.

. 2019 Jul;51(7):1194.

doi: 10.1038/s41588-019-0451-6.

Authors

Affiliations

¹ Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
² Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
³ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
⁴ Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
⁵ Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
⁶ Department of Medicine, University of Washington, Seattle, WA, USA.
⁷ Department of Laboratory Medicine, University of Washington, Seattle, WA, USA.
⁸ Department of Urology, University of Washington, Seattle, WA, USA.
⁹ Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
¹⁰ Department of Medicine, Division of Medical Oncology, Weill Cornell Medicine, New York, NY, USA.
¹¹ Englander Institute for Precision Medicine, Weill Cornell Medical College-New York Presbyterian Hospital, New York, NY, USA.
¹² Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College, New York, NY, USA.
¹³ Biomarkers Team, Division of Clinical Studies, The Institute of Cancer Research and Royal Marsden Hospital, London, UK.
¹⁴ Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.
¹⁵ Centre for Integrated Biology, University of Trento, Trento, Italy.
¹⁶ Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
¹⁷ Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
¹⁸ Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. schultzn@mskcc.org.
¹⁹ Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. schultzn@mskcc.org.
²⁰ Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. schultzn@mskcc.org.
²¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. eliezerm_vanallen@dfci.harvard.edu.
²² Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA. eliezerm_vanallen@dfci.harvard.edu.

PMID: 31152158
DOI: 10.1038/s41588-019-0451-6

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

PubMed Disclaimer

Erratum for

The long tail of oncogenic drivers in prostate cancer.
Armenia J, Wankowicz SAM, Liu D, Gao J, Kundra R, Reznik E, Chatila WK, Chakravarty D, Han GC, Coleman I, Montgomery B, Pritchard C, Morrissey C, Barbieri CE, Beltran H, Sboner A, Zafeiriou Z, Miranda S, Bielski CM, Penson AV, Tolonen C, Huang FW, Robinson D, Wu YM, Lonigro R, Garraway LA, Demichelis F, Kantoff PW, Taplin ME, Abida W, Taylor BS, Scher HI, Nelson PS, de Bono JS, Rubin MA, Sawyers CL, Chinnaiyan AM; PCF/SU2C International Prostate Cancer Dream Team; Schultz N, Van Allen EM. Armenia J, et al. Nat Genet. 2018 May;50(5):645-651. doi: 10.1038/s41588-018-0078-z. Epub 2018 Apr 2. Nat Genet. 2018. PMID: 29610475 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Publisher Correction: The long tail of oncogenic drivers in prostate cancer

Affiliations

Publisher Correction: The long tail of oncogenic drivers in prostate cancer

Authors

Affiliations

Abstract

Erratum for

Publication types

LinkOut - more resources

Full Text Sources